Skip to main content

Becton Dickinson and Company(BDX-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low154.65
Day High157.65
Open:157.34
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Piper Sandler Remains a Hold on Becton Dickinson (BDX)
Becton Dickinson announces planned interventional segment leadership transition
Analysts’ Opinions Are Mixed on These Healthcare Stocks: DaVita (DVA), BridgeBio Pharma (BBIO) and Becton Dickinson (BDX)
Wall Street Analysts Are Bullish on Top Healthcare Picks
Analysts Offer Insights on Healthcare Companies: Owlet (OWLT) and Becton Dickinson (BDX)
Citi Sticks to Their Buy Rating for Becton Dickinson (BDX)
Barclays Sticks to Their Buy Rating for Becton Dickinson (BDX)
Analysts Offer Insights on Healthcare Companies: Astrana Health (ASTH), Becton Dickinson (BDX) and United Therapeutics (UTHR)
Analysts’ Top Healthcare Picks: Becton Dickinson (BDX), United Therapeutics (UTHR)
Analysts Are Bullish on Top Healthcare Stocks: Arcutis Biotherapeutics (ARQT), Kymera Therapeutics (KYMR)
RBC Capital Keeps Their Hold Rating on Becton Dickinson (BDX)
Becton Dickinson Expands Debt Tender Offers Amid Strong Demand
Becton Dickinson (BDX) Gets a Buy from Jefferies
J.P. Morgan Reaffirms Their Hold Rating on Becton Dickinson (BDX)
Becton Dickinson Launches $1.6 Billion Debt Tender Offers
Waters resumed with an In Line at Evercore ISI
Wells Fargo Keeps Their Hold Rating on Becton Dickinson (BDX)

Profile

Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.